Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000189728 | SCV000243376 | uncertain significance | not provided | 2014-02-06 | criteria provided, single submitter | clinical testing | p.Ser42Gly (AGT>GGT): c.124 A>G in exon 3 of the TCF4 gene (NM_001083962.1). The Ser42Gly missense change in the TCF4 gene has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a non-conservative amino acid substitution of a polar Serine residue with a non-polar Glycine residue at a position that is conserved across species. However, in silico analysis predicts this variant likely has a benign effect on the protein structure/function. Therefore, based on the currently available information, it is unclear whether Ser42Gly is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). |
Baylor Genetics | RCV001336173 | SCV001529495 | uncertain significance | Pitt-Hopkins syndrome | 2018-08-22 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |